American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update

J Oral Maxillofac Surg. 2009 May;67(5 Suppl):2-12. doi: 10.1016/j.joms.2009.01.009.

Authors

Salvatore L Ruggiero¹, Thomas B Dodson, Leon A Assael, Regina Landesberg, Robert E Marx, Bhoomi Mehrotra; American Association of Oral and Maxillofacial Surgeons

Affiliation

¹ Division of Oral and Maxillofacial Surgery, Stony Brook School of Dental Medicine, Long Island Jewish Medical Center, New Hyde Park, NY, USA. drruggiero@nycoms.com

PMID: 19371809
DOI: 10.1016/j.joms.2009.01.009

No abstract available

MeSH terms

Administration, Oral
Bone Density Conservation Agents / administration & dosage
Bone Density Conservation Agents / adverse effects*
Bone Neoplasms / drug therapy
Consensus
Diagnosis, Differential
Diphosphonates / administration & dosage
Diphosphonates / adverse effects*
Humans
Incidence
Injections, Intravenous
Jaw Diseases / chemically induced*
Jaw Diseases / diagnosis
Jaw Diseases / epidemiology
Jaw Diseases / therapy
Multiple Myeloma / drug therapy
Oral Surgical Procedures
Osteonecrosis / chemically induced*
Osteonecrosis / diagnosis
Osteonecrosis / epidemiology
Osteonecrosis / therapy
Osteoporosis / prevention & control
Risk Assessment
Societies, Dental*
United States / epidemiology

Substances

Bone Density Conservation Agents
Diphosphonates